Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 2007; Volume 71,Issue 6

MINIREVIEW

  • You have access
    Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects
    Maurizio Bifulco, Claudia Grimaldi, Patrizia Gazzerro, Simona Pisanti and Antonietta Santoro
    Molecular Pharmacology June 2007, 71 (6) 1445-1456; DOI: https://doi.org/10.1124/mol.106.033118

Accelerated Communication

  • You have access
    Induction of Estrogen Receptor α Expression with Decoy Oligonucleotide Targeted to NFATc1 Binding Sites in Osteoblasts
    Letizia Penolazzi, Margherita Zennaro, Elisabetta Lambertini, Elisa Tavanti, Elena Torreggiani, Roberto Gambari and Roberta Piva
    Molecular Pharmacology June 2007, 71 (6) 1457-1462; DOI: https://doi.org/10.1124/mol.107.034561

Articles

  • You have access
    Modified Receptor Internalization upon Coexpression of 5-HT1B Receptor and 5-HT2B Receptors
    Agnes Janoshazi, Maud Deraet, Jacques Callebert, Vincent Setola, Silke Guenther, Bruno Saubamea, Philippe Manivet, Jean-Marie Launay and Luc Maroteaux
    Molecular Pharmacology June 2007, 71 (6) 1463-1474; DOI: https://doi.org/10.1124/mol.106.032656
  • You have access
    Induction of Cyp1a1 Is a Nonspecific Biomarker of Aryl Hydrocarbon Receptor Activation: Results of Large Scale Screening of Pharmaceuticals and Toxicants in Vivo and in Vitro
    Wenyue Hu, Claudio Sorrentino, Michael S. Denison, Kyle Kolaja and Mark R. Fielden
    Molecular Pharmacology June 2007, 71 (6) 1475-1486; DOI: https://doi.org/10.1124/mol.106.032748
  • You have access
    Identification of Essential Histidine and Cysteine Residues of the H+/Organic Cation Antiporter Multidrug and Toxin Extrusion (MATE)
    Jun-ichi Asaka, Tomohiro Terada, Masahiro Tsuda, Toshiya Katsura and Ken-ichi Inui
    Molecular Pharmacology June 2007, 71 (6) 1487-1493; DOI: https://doi.org/10.1124/mol.106.032938
  • You have access
    Interaction and Inhibitory Cross-Talk between Endothelin and ErbB Receptors in the Adult Heart
    Ka Young Chung and Jeffery W. Walker
    Molecular Pharmacology June 2007, 71 (6) 1494-1502; DOI: https://doi.org/10.1124/mol.106.027599
  • You have access
    Chromanol 293B Binding in KCNQ1 (Kv7.1) Channels Involves Electrostatic Interactions with a Potassium Ion in the Selectivity Filter
    Christian Lerche, Iva Bruhova, Holger Lerche, Klaus Steinmeyer, Aguan D. Wei, Nathalie Strutz-Seebohm, Florian Lang, Andreas E. Busch, Boris S. Zhorov and Guiscard Seebohm
    Molecular Pharmacology June 2007, 71 (6) 1503-1511; DOI: https://doi.org/10.1124/mol.106.031682
  • You have access
    Mutation Studies of Ser7.39 and Ser2.60 in the Human CB1 Cannabinoid Receptor: Evidence for a Serine-Induced Bend in CB1 Transmembrane Helix 7
    Ankur Kapur, Dow P. Hurst, Daniel Fleischer, Rob Whitnell, Ganesh A. Thakur, Alexandros Makriyannis, Patricia H. Reggio and Mary E. Abood
    Molecular Pharmacology June 2007, 71 (6) 1512-1524; DOI: https://doi.org/10.1124/mol.107.034645
  • You have access
    Proteasome-Regulated ERBB2 and Estrogen Receptor Pathways in Breast Cancer
    Corina Marx, Christina Yau, Surita Banwait, Yamei Zhou, Gary K. Scott, Byron Hann, John W. Park and Christopher C. Benz
    Molecular Pharmacology June 2007, 71 (6) 1525-1534; DOI: https://doi.org/10.1124/mol.107.034090
  • You have access
    Mechanism of Thiazolidinedione-Dependent Cell Death in Jurkat T Cells
    Mathias Soller, Stefan Dröse, Ulrich Brandt, Bernhard Brüne and Andreas von Knethen
    Molecular Pharmacology June 2007, 71 (6) 1535-1544; DOI: https://doi.org/10.1124/mol.107.034371
  • You have access
    Selective Activation of Liver X Receptors by Acanthoic Acid-Related Diterpenes
    Paqui G. Traves, Sonsoles Hortelano, Miriam Zeini, Ta-Hsiang Chao, Thanh Lam, Saskia T. Neuteboom, Emmanuel A. Theodorakis, Michael A. Palladino, Antonio Castrillo and Lisardo Bosca
    Molecular Pharmacology June 2007, 71 (6) 1545-1553; DOI: https://doi.org/10.1124/mol.106.031906
  • You have access
    Phosphatase and Tensin Homolog Deleted on Chromosome 10 Suppression Is an Important Process in Peroxisome Proliferator-Activated Receptor-γ Signaling in Adipocytes and Myotubes
    Ki Young Kim, Hyun Sill Cho, Won Hoon Jung, Sung Soo Kim and Hyae Gyeong Cheon
    Molecular Pharmacology June 2007, 71 (6) 1554-1562; DOI: https://doi.org/10.1124/mol.106.031948
  • You have access
    Pharmacology of α-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice
    Outi Salminen, Jennifer A. Drapeau, J. Michael McIntosh, Allan C. Collins, Michael J. Marks and Sharon R. Grady
    Molecular Pharmacology June 2007, 71 (6) 1563-1571; DOI: https://doi.org/10.1124/mol.106.031492
  • You have access
    α2A Adrenergic Receptor Activation Inhibits Epileptiform Activity in the Rat Hippocampal CA3 Region
    Chris W. D. Jurgens, Hana M. Hammad, Jessica A. Lichter, Sarah J. Boese, Brian W. Nelson, Brianna L. Goldenstein, Kylie L. Davis, Ke Xu, Kristin L. Hillman, James E. Porter and Van A. Doze
    Molecular Pharmacology June 2007, 71 (6) 1572-1581; DOI: https://doi.org/10.1124/mol.106.031773
  • You have access
    Natural and Enantiomeric Etiocholanolone Interact with Distinct Sites on the Rat α1β2γ2L GABAA Receptor
    Ping Li, John Bracamontes, Bryson W. Katona, Douglas F. Covey, Joe Henry Steinbach and Gustav Akk
    Molecular Pharmacology June 2007, 71 (6) 1582-1590; DOI: https://doi.org/10.1124/mol.106.033407
  • You have access
    Involvement of MRP4 (ABCC4) in the Luminal Efflux of Ceftizoxime and Cefazolin in the Kidney
    Lei Ci, Hiroyuki Kusuhara, Masashi Adachi, John D. Schuetz, Kenji Takeuchi and Yuichi Sugiyama
    Molecular Pharmacology June 2007, 71 (6) 1591-1597; DOI: https://doi.org/10.1124/mol.106.031823
  • You have access
    Involvement of a Dysfunctional Dopamine-D1/N-Methyl-d-aspartate-NR1 and Ca2+/Calmodulin-Dependent Protein Kinase II Pathway in the Impairment of Latent Learning in a Model of Schizophrenia Induced by Phencyclidine
    Akihiro Mouri, Yukihiro Noda, Akihiro Noda, Tomonobu Nakamura, Takanobu Tokura, Yoshimitsu Yura, Atsumi Nitta, Hiroshi Furukawa and Toshitaka Nabeshima
    Molecular Pharmacology June 2007, 71 (6) 1598-1609; DOI: https://doi.org/10.1124/mol.106.032961
  • You have access
    The Kinetics of Inhibition of Human Acetylcholinesterase and Butyrylcholinesterase by Two Series of Novel Carbamates
    Efrat Groner, Yacov Ashani, Donna Schorer-Apelbaum, Jeffrey Sterling, Yaacov Herzig and Marta Weinstock
    Molecular Pharmacology June 2007, 71 (6) 1610-1617; DOI: https://doi.org/10.1124/mol.107.033928
  • You have access
    The Relaxin Family Peptide Receptor 3 Activates Extracellular Signal-Regulated Kinase 1/2 through a Protein Kinase C-Dependent Mechanism
    Emma T. van der Westhuizen, Tim D. Werry, Patrick M. Sexton and Roger J. Summers
    Molecular Pharmacology June 2007, 71 (6) 1618-1629; DOI: https://doi.org/10.1124/mol.106.032763
  • You have access
    Identification and Functional Analysis of a Novel Human CYP2E1 Far Upstream Enhancer
    Jeff D. Shadley, Karthika Divakaran, Kimber Munson, Ronald N. Hines, Kirk Douglas and D. Gail McCarver
    Molecular Pharmacology June 2007, 71 (6) 1630-1639; DOI: https://doi.org/10.1124/mol.106.031302
  • You have access
    Inhibition of Tumor Necrosis Factor-α through Selective Blockade of Pre-mRNA Splicing by Shikonin
    Shao-Chih Chiu and Ning-Sun Yang
    Molecular Pharmacology June 2007, 71 (6) 1640-1645; DOI: https://doi.org/10.1124/mol.106.032821
  • You have access
    Subunit-Stoichiometric Evidence for Kir6.2 Channel Gating, ATP Binding, and Binding-Gating Coupling
    Runping Wang, Xiaoli Zhang, Ningren Cui, Jianping Wu, Hailan Piao, Xueren Wang, Junda Su and Chun Jiang
    Molecular Pharmacology June 2007, 71 (6) 1646-1656; DOI: https://doi.org/10.1124/mol.106.030528
  • You have access
    Inhibition of Vascular Endothelial Growth Factor Cotranslational Translocation by the Cyclopeptolide CAM741
    Hanna Harant, Barbara Wolff, Erwin P. Schreiner, Berndt Oberhauser, Lotte Hofer, Nicole Lettner, Sabine Maier, Jan E. de Vries and Ivan J. Lindley
    Molecular Pharmacology June 2007, 71 (6) 1657-1665; DOI: https://doi.org/10.1124/mol.107.034249
  • You have access
    Gαq-Mediated Regulation of TASK3 Two-Pore Domain Potassium Channels: The Role of Protein Kinase C
    Emma L. Veale, Louise E. Kennard, Gemma L. Sutton, Georgina MacKenzie, Cristina Sandu and Alistair Mathie
    Molecular Pharmacology June 2007, 71 (6) 1666-1675; DOI: https://doi.org/10.1124/mol.106.033241
  • You have access
    Quercetin Activates an Angiogenic Pathway, Hypoxia Inducible Factor (HIF)-1-Vascular Endothelial Growth Factor, by Inhibiting HIF-Prolyl Hydroxylase: a Structural Analysis of Quercetin for Inhibiting HIF-Prolyl Hydroxylase
    Hyunchu Jeon, Heejung Kim, Daekyu Choi, Duksoo Kim, Shi-Young Park, Yung-Jin Kim, Young Mi Kim and Yunjin Jung
    Molecular Pharmacology June 2007, 71 (6) 1676-1684; DOI: https://doi.org/10.1124/mol.107.034041
  • You have access
    The Amine-Containing Cutaneous Irritant Heptylamine Inhibits the Volume-Regulated Anion Channel and Mobilizes Intracellular Calcium in Normal Human Epidermal Keratinocytes
    Matthieu Raoux, Cécile Colomban, Patrick Delmas and Marcel Crest
    Molecular Pharmacology June 2007, 71 (6) 1685-1694; DOI: https://doi.org/10.1124/mol.106.033324
  • You have access
    The Thiazolidinedione Pioglitazone Alters Mitochondrial Function in Human Neuron-Like Cells
    Sangeeta Ghosh, Nishant Patel, Douglas Rahn, Jenna McAllister, Sina Sadeghi, Geoffrey Horwitz, Diana Berry, Kai Xuan Wang and Russell H. Swerdlow
    Molecular Pharmacology June 2007, 71 (6) 1695-1702; DOI: https://doi.org/10.1124/mol.106.033845
  • You have access
    Fisetin, an Inhibitor of Cyclin-Dependent Kinase 6, Down-Regulates Nuclear Factor-κB-Regulated Cell Proliferation, Antiapoptotic and Metastatic Gene Products through the Suppression of TAK-1 and Receptor-Interacting Protein-Regulated IκBα Kinase Activation
    Bokyung Sung, Manoj K. Pandey and Bharat B. Aggarwal
    Molecular Pharmacology June 2007, 71 (6) 1703-1714; DOI: https://doi.org/10.1124/mol.107.034512
  • You have access
    Pioglitazone and Rosiglitazone Decrease Prostaglandin E2 in Non–Small-Cell Lung Cancer Cells by Up-Regulating 15-Hydroxyprostaglandin Dehydrogenase
    Saswati Hazra, Raj K. Batra, Hsin H. Tai, Sherven Sharma, Xiaoyan Cui and Steven M. Dubinett
    Molecular Pharmacology June 2007, 71 (6) 1715-1720; DOI: https://doi.org/10.1124/mol.106.033357
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 71 (6)
Molecular Pharmacology
Vol. 71, Issue 6
1 Jun 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • MINIREVIEW
  • Accelerated Communication
  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics